Showing results (211-220 of 445) with videos related to
Sort By:
Pageof 45
Frontiers in Cardiovascular Medicine|January 1, 2026
Dysfunctional high-density lipoprotein: an updated reviewFrances W Ouyang, Huan-Hsing Chiang, Wen-Li Hsu, et al.Journal of Clinical Lipidology|November 20, 2019
Colchicine's effects on lipoprotein particle concentrations in adults with metabolic syndrome: A secondary analysis of a randomized controlled trialAndrew P Demidowich, Anna Wolska, Sierra R Wilson, et al.International Journal of Laboratory Hematology|August 29, 2018
GlycA is not a useful biomarker of inflammation in sickle cell diseaseJulie K Weisman, Daveena Meeks, Laurel Mendelsohn, et al.Fertility and Sterility|July 31, 2007
Gynecologic and hormonal effects of raloxifene in premenopausal womenAhalya Premkumar, David J Venzon, Nilo Avila, et al.JAMA|June 5, 2008
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart diseaseRuth Frikke-Schmidt, Børge G Nordestgaard, Maria C A Stene, et al.The Journal of Biological Chemistry|August 2, 2020
High-density lipoproteins are a potential therapeutic target for age-related macular degenerationUna L Kelly, Daniel Grigsby, Martha A Cady, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancerRaffit Hassan, Alan T Remaley, Maureen L Sampson, et al.Cancer Research|July 5, 2002
Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathwayIsaac Yi Kim, Do Hwan Seong, Byung-Chul Kim, et al.Lipids in Health and Disease|August 23, 2020
Effect of niacin monotherapy on high density lipoprotein composition and functionScott M Gordon, Marcelo J Amar, Kianoush Jeiran, et al.Nutrients|February 26, 2025
Endogenous Ketone Bodies Are Associated with Metabolic Vulnerability and Disability in Multiple SclerosisTaylor R Wicks, Irina Shalaurova, Anna Wolska, et al.Pageof 45